Latest News
Is Lunar Dust Harmful to Humans?
News Apr 17, 2011Exposure to lunar dust during the Apollo missions resulted in reports of ocular, respiratory and dermal irritation, suggesting that lunar dust is a potential risk to human health.
READ MORE
Study Shows Patient’s Own Cells may Hold Therapeutic Promise After Reprogramming, Gene Correction
News Apr 13, 2011Scientists determine that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.
READ MORE
Distribution of Cancers in the HIV/AIDS Population is Shifting
News Apr 12, 2011While cases of the types of cancer that have been associated with AIDS progression have decreased, cases of other types of cancer are on the rise.
READ MORE
Dako Appoints New CFO
News Apr 08, 2011Egil Molsted Madsen is appointed new CFO of Dako A/S and Dako Denmark.
READ MORE
Proteome of Human Colon Cancer Stem Cells: A Comparative Analysis
News Apr 05, 2011A recent article details how researchers have isolated and identified the biological characteristics of human colon cancer stem cells (SW1116 cells) and further studied their proteome.
READ MORE
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
News Apr 04, 2011Merger to facilitate the initiation of the NeuVax™ phase III trial in HER2 positive patients not eligible for Herceptin® in 1H 2012.
READ MORE
Studies on Sea Snake Venom
News Apr 04, 2011A review article published in the Proceedings of the Japan Academy describes how X-ray crystallography and NMR spectroscopy were employed to study sea snake venom.
READ MORE
Report to Nation Finds Continued Declines in Many Cancer Rates
News Apr 03, 2011According to the latest Annual Report to the Nation on the Status of Cancer, rates of death in the United States from all cancers for men and women continued to decline between 2003 and 2007.
READ MORE
Critical Outcome Technologies Completes Financing
News Mar 31, 2011Completion of first tranche of a non-brokered private placement and issued 8,152,500 units at a price of $0.16 per Unit for gross proceeds of $1,304,400.
READ MORE
Viral Replicase Points to Potential Cancer Therapy
News Mar 31, 2011New research demonstrates that an artificial plasmid coding for the replicase genes of Sindbis virus causes regression and destruction of lung cancer, or melanoma, cells in mice.
READ MORE
